vs

Side-by-side financial comparison of CISO Global, Inc. (CISO) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

CISO Global, Inc. is the larger business by last-quarter revenue ($6.3M vs $3.8M, roughly 1.6× Vivos Therapeutics, Inc.). CISO Global, Inc. runs the higher net margin — -35.4% vs -180.3%, a 144.9% gap on every dollar of revenue. On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -15.4%). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -11.6%).

CISO Global, Inc. is a specialized cybersecurity services provider. It offers managed security monitoring, risk assessment, compliance advisory and incident response, serving North American SMEs, government and commercial clients across healthcare, retail and finance to help safeguard digital assets and mitigate cyber risks.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

CISO vs VVOS — Head-to-Head

Bigger by revenue
CISO
CISO
1.6× larger
CISO
$6.3M
$3.8M
VVOS
Growing faster (revenue YoY)
VVOS
VVOS
+18.8% gap
VVOS
3.4%
-15.4%
CISO
Higher net margin
CISO
CISO
144.9% more per $
CISO
-35.4%
-180.3%
VVOS
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-11.6%
CISO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CISO
CISO
VVOS
VVOS
Revenue
$6.3M
$3.8M
Net Profit
$-2.2M
$-6.9M
Gross Margin
28.6%
78.1%
Operating Margin
-33.7%
-166.8%
Net Margin
-35.4%
-180.3%
Revenue YoY
-15.4%
3.4%
Net Profit YoY
59.8%
-143.8%
EPS (diluted)
$0.10
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CISO
CISO
VVOS
VVOS
Q4 25
$6.3M
$3.8M
Q3 25
$6.5M
$6.8M
Q2 25
$6.7M
$3.8M
Q1 25
$7.2M
$3.0M
Q4 24
$7.4M
$3.7M
Q3 24
$7.5M
$3.9M
Q2 24
$7.8M
$4.1M
Q1 24
$8.0M
$3.4M
Net Profit
CISO
CISO
VVOS
VVOS
Q4 25
$-2.2M
$-6.9M
Q3 25
$2.5M
$-5.4M
Q2 25
$-3.0M
$-5.0M
Q1 25
$-5.4M
$-3.9M
Q4 24
$-5.5M
$-2.8M
Q3 24
$-3.7M
$-2.6M
Q2 24
$-8.4M
$-1.9M
Q1 24
$-6.6M
$-3.8M
Gross Margin
CISO
CISO
VVOS
VVOS
Q4 25
28.6%
78.1%
Q3 25
24.9%
58.0%
Q2 25
24.4%
55.2%
Q1 25
24.9%
50.0%
Q4 24
24.8%
56.7%
Q3 24
13.8%
60.5%
Q2 24
12.0%
65.4%
Q1 24
8.8%
56.7%
Operating Margin
CISO
CISO
VVOS
VVOS
Q4 25
-33.7%
-166.8%
Q3 25
-40.8%
-69.8%
Q2 25
-34.7%
-127.4%
Q1 25
-23.9%
-129.9%
Q4 24
-26.1%
-75.9%
Q3 24
-46.8%
-68.5%
Q2 24
-54.3%
-47.8%
Q1 24
-61.0%
-110.7%
Net Margin
CISO
CISO
VVOS
VVOS
Q4 25
-35.4%
-180.3%
Q3 25
39.2%
-79.6%
Q2 25
-44.8%
-131.2%
Q1 25
-75.1%
-128.1%
Q4 24
-74.5%
-76.4%
Q3 24
-49.0%
-67.8%
Q2 24
-108.0%
-47.6%
Q1 24
-82.4%
-110.1%
EPS (diluted)
CISO
CISO
VVOS
VVOS
Q4 25
$0.10
$-0.58
Q3 25
$-0.05
$-0.49
Q2 25
$-0.09
$-0.55
Q1 25
$-0.38
$-0.45
Q4 24
$-0.47
$0.41
Q3 24
$-0.32
$-0.40
Q2 24
$-0.69
$-0.60
Q1 24
$-0.55
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CISO
CISO
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$1.7M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$14.8M
$-1.5M
Total Assets
$25.0M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CISO
CISO
VVOS
VVOS
Q4 25
$1.7M
$2.0M
Q3 25
$1.1M
$3.1M
Q2 25
$760.8K
$4.4M
Q1 25
$1.8M
$2.3M
Q4 24
$992.6K
$6.3M
Q3 24
$443.1K
$6.3M
Q2 24
$1.1M
$6.9M
Q1 24
$1.5M
$2.6M
Total Debt
CISO
CISO
VVOS
VVOS
Q4 25
$2.9M
Q3 25
$2.1M
Q2 25
$9.9M
Q1 25
$10.6M
Q4 24
$11.7M
$1.2M
Q3 24
$11.9M
$1.2M
Q2 24
$12.8M
$1.2M
Q1 24
$15.1M
Stockholders' Equity
CISO
CISO
VVOS
VVOS
Q4 25
$14.8M
$-1.5M
Q3 25
$16.3M
$2.5M
Q2 25
$7.6M
$4.6M
Q1 25
$7.0M
$4.4M
Q4 24
$1.1M
$8.0M
Q3 24
$3.0M
$7.7M
Q2 24
$5.6M
$6.3M
Q1 24
$11.2M
$582.0K
Total Assets
CISO
CISO
VVOS
VVOS
Q4 25
$25.0M
$25.2M
Q3 25
$25.1M
$25.6M
Q2 25
$25.8M
$26.0M
Q1 25
$27.8M
$11.3M
Q4 24
$26.7M
$15.3M
Q3 24
$26.6M
$15.3M
Q2 24
$43.2M
$15.8M
Q1 24
$47.5M
$11.8M
Debt / Equity
CISO
CISO
VVOS
VVOS
Q4 25
Q3 25
0.13×
Q2 25
1.31×
Q1 25
1.52×
Q4 24
10.20×
0.15×
Q3 24
3.92×
0.16×
Q2 24
2.27×
0.19×
Q1 24
1.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CISO
CISO
VVOS
VVOS
Operating Cash FlowLast quarter
$-1.8M
$-3.8M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-139.7%
Capex IntensityCapex / Revenue
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CISO
CISO
VVOS
VVOS
Q4 25
$-1.8M
$-3.8M
Q3 25
$-876.7K
$-4.2M
Q2 25
$-2.3M
$-3.5M
Q1 25
$-3.0M
$-3.8M
Q4 24
$-259.0K
$-2.9M
Q3 24
$-903.1K
$-4.2M
Q2 24
$-1.3M
$-3.0M
Q1 24
$-1.4M
$-2.5M
Free Cash Flow
CISO
CISO
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-4.2M
Q2 25
$-4.3M
Q1 25
$-3.9M
Q4 24
$-3.1M
Q3 24
$-4.4M
Q2 24
$-1.3M
$-3.1M
Q1 24
$-1.5M
$-2.7M
FCF Margin
CISO
CISO
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-62.6%
Q2 25
-111.6%
Q1 25
-129.9%
Q4 24
-84.0%
Q3 24
-113.4%
Q2 24
-16.4%
-76.7%
Q1 24
-18.5%
-78.0%
Capex Intensity
CISO
CISO
VVOS
VVOS
Q4 25
40.0%
Q3 25
1.2%
Q2 25
20.2%
Q1 25
4.0%
Q4 24
0.0%
4.5%
Q3 24
0.0%
5.0%
Q2 24
0.1%
1.5%
Q1 24
0.9%
4.4%
Cash Conversion
CISO
CISO
VVOS
VVOS
Q4 25
Q3 25
-0.35×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CISO
CISO

Security Managed Services$5.4M87%
Other$823.3K13%

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons